[1] |
Komaya K, Ebata T, Yokoyama Y, et al. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach[J]. Surgery, 2018, 163(4):732-738.
|
[2] |
陈孝平, 项帅. 精准医学时代肝门部胆管癌的治疗[J]. 中华消化外科杂志, 2018, 17(1):3-8.
|
[3] |
刘颖斌, 吴向嵩, 李茂岚, 等. 胆囊癌外科治疗的热点与争议[J]. 中华消化外科杂志, 2018, 17(3):225-228.
|
[4] |
Cho JK, Lee W, Jang JY, et al. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study[J]. World J Surg Oncol, 2019, 17(1):8.
|
[5] |
Pang L, Zhang Y, Wang Y, et al. Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma: an overview[J]. Braz J Med Biol Res, 2018, 51(6):e7411.
|
[6] |
Høgdall D, Lewinska M, Andersen JB. Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma[J]. Trends Cancer, 2018, 4(3):239-255.
|
[7] |
Blechacz B, Komuta M, Roskams T, et al. Clinical diagnosis and staging of cholangiocarcinoma[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(9):512-522.
|
[8] |
徐艺, 王浩, 崔云甫. 远端胆管癌的治疗进展[J]. 世界华人消化杂志, 2014, 22(28):4263-4269.
|
[9] |
王鹏飞, 朱自满, 蔡守旺. 肝门部胆管癌的切除与重建[J]. 临床外科杂志, 2017, 25(3):177-178.
|
[10] |
De Jong MC, Marques H, Clary BM, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases[J]. Cancer, 2012, 118(19):4737-4747.
|
[11] |
Neuhaus P, Thelen A, Jonas S, et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma[J]. Ann Surg Oncol, 2012, 19(5):1602-1608.
|
[12] |
戴海粟, 别平, 王曙光, 等. 联合肝动脉切除重建在肝门部胆管癌根治术中的临床研究[J]. 中华外科杂志, 2018, 56(1):41-46.
|
[13] |
梁雨荣, 石雍, 王敬, 等. 肝门部胆管癌手术中胃十二指肠动脉搭桥在肝动脉重建中的应用[J]. 中华肝胆外科杂志, 2013, 19(12):895-897.
|
[14] |
汤朝晖, 魏妙艳, 唐陈伟, 等. 肝门部胆管癌根治术区域淋巴结清扫范围探讨[J]. 中国普外基础与临床杂志, 2018, 25(7):775-778.
|
[15] |
Giuliante F, Ardito F, Guglielmi A, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis[J]. JAMA Surg, 2016, 151(10): 916-922.
|
[16] |
杨晖, 关志伟, 富丽萍, 等. 18F-FD GPET/CT在肝外胆管细胞癌术前诊断及分期中的价值[J]. 中华核医学与分子影像杂志, 2017, 37(2):65-69.
|
[17] |
李海民, 窦科峰, 孙凯, 等. 肝门部胆管癌姑息性手术179例[J]. 中华普通外科杂志, 2002, 17(5):267-268.
|
[18] |
张伟峰, 王松松. 三种姑息性方案在肝门部胆管癌治疗中应用比较[J]. 肝胆外科杂志, 2017, 25(1):33-36.
|
[19] |
Azad AI, Rosen CB, Taner T, et al. Selected patients with unresectable perihilar cholangiocarcinoma (pCCA) derive long-term benefit from liver transplantation[J]. Cancers, 2020, 12(11):3157.
|
[20] |
吴幼民, Johlin FC, Rayhill SC,等. 早期肝门部胆管癌放疗联合肝胰十二指肠整块切除和原位肝移植后患者长期无瘤存活情况报告[J]. 中华外科杂志, 2009, 47(15):1155-1161.
|
[21] |
朱鸿超, 周龙飞, 刘天德, 等. 腹腔镜与开腹Bismuth-Ⅰ型肝门胆管癌根治术的疗效分析[J]. 中国内镜杂志, 2018, 24(2):10-15.
|
[22] |
张成武, 刘杰, 尚敏杰, 等. 完全腹腔镜下Ⅲa型肝门部胆管癌根治性切除术[J]. 中华普通外科杂志, 2017, 32(8):691-693.
|
[23] |
尹新民, 刘雅玲, 成伟, 等. 全腹腔镜Ⅳ型肝门部胆管癌根治术的临床应用价值(附视频)[J/CD]. 中华肝脏外科手术学电子杂志, 2018, 7(2):110-114.
|
[24] |
陈泽峰. 肝门部胆管癌达芬奇机器人辅助手术和开腹手术治疗的临床比较研究[D]. 太原:山西医科大学, 2012.
|
[25] |
刘荣, 赵国栋, 宋昱垚,等. 机器人Ⅲ型肝门部胆管癌根治术[J/CD]. 中华腔镜外科杂志(电子版), 2015, 8(6):439-440.
|